Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells-Reference-Cited by-同舟云学术

Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells

Published:2010-04-14 Issue:3 Volume:28 Page:878-887
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Guo Zhenghui,Huang Hai,Zeng Lexiang,Du Tao,Xu Kewei,Lin Tianxin,Jiang Chun,Dong Wen,Cao Yi,Chen Jieqing,Zhong WeiDe,Huang Jian

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-010-9524-1.pdf

Reference30 articles.

1. Graham J, Baker M, Macbeth F, Titshall V. Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ. 2008;336:610–2.

2. Cuzick J, Fisher G, Kattan MW, Berney D, Oliver T, Foster CS, et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer. 2006;95:1186–94.

3. Kakehi Y. Watchful waiting as a treatment option for localized prostate cancer in the PSA era. Jpn J Clin Oncol. 2003;33:1–5.

4. Rubin MA. Targeted therapy of cancer: new roles for pathologists-prostate cancer. Mod Pathol. 2008;21(Suppl. 2):S44–55.

5. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349:366–81.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Role of Prostate-Specific Membrane Antigen in Telomere Stability in Prostate Cancer Cells;Molecular Cancer Research;2023-08-09

2. Correction to: Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells;Medical Oncology;2021-07-24

3. Molecular and cellular mechanisms of castration resistant prostate cancer (Review);Oncology Letters;2018-02-27

4. Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo;Nanomedicine: Nanotechnology, Biology and Medicine;2016-11

5. The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease;British Journal of Pharmacology;2016-09-23